Inactive Instrument

Highlights CinCor Pharma, Inc.

Equities

CINC

US17240Y1091

Highlights

Unlock all the news: Be the first to know and act before the market!

AstraZeneca Completes $1.8 Billion Acquisition of CinCor Pharma to Boost Cardiorenal Portfolio	23-02-24	MT
AstraZeneca closes CinCor buy; Enhertu wins Chinese approval	23-02-24	AN
Astrazeneca Finance And Holdings Inc. completed the acquisition of CinCor Pharma, Inc. from a group of shareholders.	23-02-22	CI
CinCor Pharma, Inc. Announces Completion of End-of-Phase 2 Meeting with U.S. Food and Drug Administration on Anticipated Phase 3 Program for Baxdrostat in Hypertension	23-02-21	CI
AstraZeneca Initiates Tender Offer For $2 Billion CinCor Takeover	23-01-23	MT
Biotech IPO Window to Reopen in 2023 Following Muted Activity in 2022, Oppenheimer Says	23-01-23	MT
AstraZeneca Unit Starts Tender Offer to Purchase CinCor Pharma	23-01-23	MT
CinCor Pharma Shares Take Flight on Takeover by AstraZeneca	23-01-09	DJ
North American Morning Briefing : 'Soft Landing' Rally Looks Set to Continue	23-01-09	DJ
Trending : AstraZeneca in Focus After Buying CinCor Pharma for Baxdrostat Cardiorenal Drug	23-01-09	DJ
AstraZeneca buys biotech CinCor for up to USD1.8 billion	23-01-09	AN
AstraZeneca's CinCor Acquisition Looks a Good Fit	23-01-09	DJ
AstraZeneca to Acquire CinCor Pharma	23-01-09	MT
AstraZeneca Kicks Off New Year With $1.8 Billion CinCor Pharma Buy to Expand Cardiorenal Pipeline	23-01-09	MT
FTSE 100 Poised to Rise After Upbeat Asia Trading	23-01-09	DJ
Astra makes USD1.8 billion buy; Keller hit by fraud	23-01-09	AN
AstraZeneca to Buy CinCor Pharma for Baxdrostat Cardiorenal Drug	23-01-09	DJ
AstraZeneca boosts heart, kidney business with $1.8 bln CinCor deal	23-01-09	RE
AstraZeneca Strikes $1.8 Billion Purchase Deal For Biopharma Group CinCor	23-01-09	MT
AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 billion deal	23-01-09	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CinCor Pharma, Inc.

Equities

CINC

US17240Y1091

Highlights

Filters